Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies

Gynecologic Oncology

Volumn 92, Issue 3, 2004, Pages 801-805

  Mundt, Arno J ^a,b   Rotmensch, Jacob ^a   Waggoner, Steven E ^a   Yamada, S Diane ^a   Fleming, Gini F ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cervical cancer; Chemotherapy; Phase I; Radiation therapy

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; BLOOD TOXICITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DERMATITIS; DIARRHEA; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NAUSEA; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 1342321829     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.10.017     Document Type: Conference Paper

References (31)

1. Perez C.A., Camel H.M., Kuske R.R., Kao M.S., Galakatos A., Hederman M.A.et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol. Oncol. 23:1986;127-140.
2. Montana G.S., Fowler W.C., Varia M.A., Walton L.A., Mack Y., Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer. 57:1986;148-154.
3. Million R.R., Rutledge F., Fletcher G.H. Stage IV carcinoma of the cervix with bladder invasion. Am. J. Obstet. Gynecol. 113:1972;239-246.
4. Hreshchyshyn M.M., Aron B.S., Boronow R.C., Franklin E.W., Shingleton H.M., Blessing J.A. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;317-322.
5. Malfetano J., Keys H., Kredentser D., Cunningham M., Kotlove D., Weiss L. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical cancer. Cancer. 71:1993;3703-3706.
6. Twiggs L.B., Potish R.A., McIntyre S., Adcock L.L., Savage J.E., Prem K.A. Concurrent weekly cisplatinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study. Gynecol. Oncol. 24:1986;143-148.
7. Runowicz C.D., Wadler S., Rodriquez-Rodriquez L., Litwin P., Shaves M., O'Hanlon K.A.et al. Concomitant cisplatin and radiotherapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol. Oncol. 34:1989;395-401.
8. Pearcey R.G., Stuart G.C., MacLean G.D., Nation J.G., Arthur K., Lukka H.et al. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol. Oncol. 58:1995;34-41.
9. Thigpen T., Shingleton H., Homesley H., Lagasse L., Blessing J. Cisplatinum in the treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer. 48:1981;899-903.
10. Carde P., Laval F. Effect of cis-dichlorodiammine platinum II and X-rays on mammalian cell survival. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;929-933.
11. Wallner K.E., Li G.C. Effect of cisplatinum resistance on cellular radiation response. Int. J. Radiat. Oncol. Biol. Phys. 15:1987;587-591.
12. Prestayko A., Crooke S., Carter S. Cisplatin: current status and new developments. 1980;124-147 Academic Press, New York, NY.
13. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L.et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340:1999;154-161.
14. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A.et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340:1999;1144-1153.
15. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E.et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340:1999;1137-1143.
16. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C. Jr.et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study. J. Clin. Oncol. 17:1999;1339-1348.
17. Eifel P.J. Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. J. Clin. Oncol. 17:1999;1334-1335.
18. Leveque D., Jehl F. Clinical pharmacokinetics of vinorelbine. Clin. Pharmacokinet. 31:1996;184-197.
19. Lacava J.A., Leone B.A., Machiavelli M., Romero A.O., Perez J.E., Elem Y.L.et al. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma. J. Clin. Oncol. 15:1997;604-609.
20. Morris M., Brader K.R., Levenback C., Burke T.W., Atkinson E.N., Scott W.R.et al. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J. Clin. Oncol. 16:1998;1094-1098.
21. Lhomme C., Vermorken J.B., Mickiewicz E., Chevalier B., Alvarez A., Mendiola C.et al. Phase II trial of vinorelbine in patients with advanced and/ or recurrent cervical carcinoma: an EORTC Gynecological Cancer Cooperative Group Study. Eur. J. Cancer. 36:2000;194-199.
22. Edelstein M.P., Wolf L.A., Duch D.S. Potentiation of radiotherapy by navelbine in a non-small cell lung cancer line. Semin. Oncol. 23:1996;41-47.
23. Mundt A.J., Rotmensch J., Waggoner S.E., Yamada S.D., Langhauser C., Fleming G.F. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol. Oncol. 82:2001;333-337.
24. Clark J.I., Kancharla K., Qamar R., Fisher S., Hantel A., Panganiban J. et al. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer. Lung Cancer. 34:2001;271-277.
25. Perng R.P., Shih J.F., Chen Y.M., Delgado F.M., Tsai C.M., Chou K.C.et al. A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small cell lung cancer. Am. J. Clin. Oncol. 23:2000;60-64.
26. Orrechia R., Jereczek-Fossa B.A., Catalona G., Chiesa F., DePas T., Masci G.et al. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer. Oncology. 63:2002;115-123.
27. Mustacchi G., Muggia M., Milani S., Ceccherini R., Leita M.L., Dellach C. A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. Ann. Oncol. 13:2002;1730-1736.
28. Conroy T., Etienne P.L., Adenis A., Ducreux M., Paillot B., Oliveira J. et al. European organization for research and treatment of cancer. Gastrointestinal Tract Cancer Cooperative Group. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the eosophagus: response, toxicity, quality of life and survival. Ann. Oncol. 13:2002;721-729.
29. Gebbia V., Testa A., Boresellino N., Ferrera P., Tirrito M., Palmeri S. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen. Ann. Oncol. 12:2001;767-772.
30. Pignata S., Silvestro G., Ferrari E., Selvaggi L., Perrone F., Maffeo A.et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J. Clin. Oncol. 17:1999;756-760.
31. Gebbia V., Caruso M., Testa A., Mauceri G., Borsellino N., Chiarenza M. et al. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix. Oncology. 63:2002;31-37.